论文部分内容阅读
[目的]观察心脑宁胶囊联合西药治疗气滞血瘀冠心病心肌缺血疗效。[方法]使用随机平行对照方法,将90例住院患者按病志号抽签方法简单随机分两组。对照组45例阿司匹林、他汀类、硝酸酯类等。治疗组45例心脑宁胶囊,3粒/次,Tid;西药治疗同对照组。连续治疗30d为1疗程。观测临床症状、心绞痛发作次数及持续时间、不良反应。治疗1疗程,判定疗效。[结果]心绞痛疗效、心肌缺血疗效、心律失常疗效两组无明显差异(P>0.05)。心绞痛发作次数及持续时间两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。[结论]心脑宁胶囊联合西药治疗气滞血瘀冠心病心肌缺血,疗效满意,无严重不良反应,值得推广。
[Objective] To observe the therapeutic effect of Xinnaoning Capsule combined with western medicine on myocardial ischemia in patients with qi stagnation and blood stasis. [Method] Using randomized parallel control method, 90 inpatients were randomly divided into two groups randomly according to the method of lot drawing. Control group, 45 cases of aspirin, statins, nitrates and so on. 45 cases of treatment group Xinnaoning Capsule, 3 capsules / time, Tid; western medicine treatment with the control group. Continuous treatment of 30d for a course of treatment. Observation of clinical symptoms, angina pectoris episodes and duration, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Result] The results of angina pectoris, myocardial ischemia and arrhythmia had no significant difference between the two groups (P> 0.05). The number and duration of angina pectoris were improved in both groups (P <0.01), and the treatment group improved better than the control group (P <0.01). [Conclusion] Xinnaoning capsule combined with Western medicine in treating myocardial ischemia with qi stagnation and blood stasis and coronary heart disease has satisfactory curative effect and no serious adverse reactions, which deserves promotion.